Overwhelmingly Positive Performance and Results from Beta Users Accelerate Product Availability to Additional Users
PALO ALTO, Calif. – October 22, 2024 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care, today announced the release of ChatRWD, after a successful beta program. The company previously published ChatRWD’s superior performance over other large language models (LLMs) when it comes to trust, quality, and accuracy (limited hallucinations).
Read the full press release
Highlights:
- Come see a live demonstration today (Tuesday October 22, 2024) at HLTHUSA 2024 on the Newsroom stage (#5046) 3:30PM PT.
“The pace of innovation in AI and LLM technologies and their adoption in healthcare is rapid,” said Neil Sanghavi, President of Atropos Health. “High-quality clinical evidence must remain the cornerstone of value in healthcare. ChatRWD’s results during the beta outperformed our expectations – both technically and on user satisfaction – which led us to today’s release.”
- ChatRWD is the first application incorporating chat-to-database capability and agents to help healthcare leaders advance and accelerate evidence generation rapidly, saving organizations valuable time, money, and staffing resources.
- Today’s release allows clinicians from health systems and life sciences organizations to set-up an account and ask two clinical questions at no charge.
- Register to use ChatRWD at https://www.atroposhealth.com/chatrwd/